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CASE REPORT

Nasal T Cell Lymphoma: A Rare Entity
Maliha Kazi1, Mubasher Ikram1 and Montasir Junaid2

ABSTRACT

Nasal type of Natural Killer (NK)/T cell lymphoma manifests in the nasal cavity. Approximately 95% of them are associated
with EBV(Ebstein Barr Virus) with a strong predilection for the Asian population. It has certain systemic and localized
symptoms which aid in diagnosis of the condition. However, the histological criteria is pivotal in confirming the diagnosis
as well as aiding in confirming the association of EBV. Nasal type of NK/T cell lymphoma has a guarded prognosis.
Treatment plan include radiotherapy with concurrent chemotherapy. Despite all this, the 5-year survival rate ranges from
15 - 75%. A 35 years old male presented with an ulcerative nasal lesion. Diagnosed as nasal type of NK/T cell lymphoma
via a tissue biopsy, it was managed by chemo-radiotherapy leading to complete resolution of symptoms and disease free
on his follow-up 6 months later.
Key Words: Nasal type of NK/T cell lymphoma. Nasal ulcer. Midface destruction. Radiation therapy. Chemotherapy.
CHOP regimen.

INTRODUCTION

The nasal type of NK/T (natural killer/T) cell lymphoma
is a rare but a slowly progressive destructive entity. The
term nasal type of NK/T cell lymphoma was first
introduced by Williams in 1949. With time, it came to be
known by multiple synonyms including Stewart's
granuloma, polymorphic reticulosis and other more
obscure terms like progressive lethal granulomatous
ulceration, malignant granuloma, midline granuloma,
non-healing granuloma, and midline malignant reticulosis.1 Nasal type of NK/T cell lymphoma occurs most
commonly in the fourth decade of life, with a female
preponderance (2:1 - 8:1).
Described below is the case of a middle aged male
presenting with nasal type of NK/T cell lymphoma and
subsequent management.

CASE REPORT

A 35 years old male, with no prior co-morbid conditions,
presented with a necrotic defect over the left ala of nose
and bridge. He had initially developed the lesion 3
months prior that had been un-responsive to multiple
antibiotic therapies. He subsequently underwent a
biopsy for it, but since he was travelling abroad, he left
before receiving the final biopsy report and hence
received no treatment for the same. As a result, the
necrotic area continued to increase in size and soon
involved the dorsum, eroding the septum, with induration
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around the malar area and inferior orbital region on the
left side (Figure 1).

Upon presentation to our department, he already had a
disfigured nose, with almost complete necrosis of the
lateral alar wall. A small part of the cartilaginous nasal
septum remained which was visible through the necrotic
area and blackened. On examination of the oral cavity,
the hard palate had blackened mucosa with a fistulous
communication in the nasal cavity. Patient denied any
history of fever or myalgias.

The patient was admitted, started on intravenous
antibiotics and his baseline investigations including
complete blood picture, electrolytes, creatinine and
blood sugars were carried out, which came out normal.
Computed tomography (CT) scan of the para nasal
sinuses was performed; it showed the disease to be
superficial, not involving the sinuses, and localized to the
midface. There was no evidence of bony destruction.
A biopsy under local anaesthesia was performed at
bedside. It showed dense lymphocytic infiltration with
angiocentric pattern of growth, characteristic of nasal
type of NK/T cell lymphoma. Further immunochemistry
performed was positive for CD56.
The gentleman was then referred to radiation and
medicine oncology. He received chemo-radiation
therapy, with radiation of 50Gy (2 Grays/fraction) given
in 5 weeks and 3 cycles of chemotherapy (CHOP
regimen:cyclophosphamide, hydroxy doxorubicin,
vincristine, prednisolone ). It led to gradual but complete
resolution of the disease (Figure 2).

He remained well after completing his treatment and on
regular follow ups-of 6 months he was disease free. He
had a 3 cm x 3 cm sized defect along the left lateral wall
of his nose. He was advised to get treated by a plastic
surgeon for the muco-cutaneous defect of his nose for
which he opted to receive treatment at local hospital in
his city.
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Figure 1: Figure showing necrotic
edges of the lesion with loss of the
septum.

Figure 2: Small defect caused due
to the destructive effect of the
lesion, requiring a local flap.

DISCUSSION

Nasal type NK / T cell lymphoma was first recognized
more than a century ago, in 1897 by McBride. He
reported a case of rapid destruction of face and nose
and facial swelling.2 The condition gained popularity in
1922, when Stewart described a case series of 10
patients with similar mid-face destructive lesions.1
Rarely reported in all races, it is more common in
Mongoloids, Indonesians and Latin Americans.3 Despite
the fact that the etiology is unknown, approximately 95%
of the cases are associated with Epstein Barr Virus
(EBV).4

Diagnosis of nasal type of NK/T cell lymphoma is based
on history, clinical examination along with pathological
findings. Symptoms may be general or with head and
neck manifestations. Constitutional symptoms like fever,
malaise, chills, rhinorrhea and weight loss usually
precede the midface destruction, none of which were
apparent in this patient. Other symptoms include
diplopia, proptosis and cranial nerve paralysis due to
involvement of local structures. Histopathology shows
invasion and destruction of blood vessels along with
superimposed bacterial infection. The histological
criteria considered in confirming the diagnosis includes:
angiocentric infiltration with or without necrosis, extra
nodal infiltration into the surrounding tissues, immunophenotype of CD56 or CD3 as well as association with
EBV.5 T/NK cell lymphoma with an association to EBV is
resistant to conventional chemotherapy and has an
immensely aggressive clinical course.6 EBV test was
performed in our patient after his initial diagnosis, which
turned out to be negative.
Studies have suggested imaging as non-specific and
only beneficial to see the extent of destruction.6 It has a
series of prodromal symptoms of persistent rhinorrhea,
stuffiness and symptoms of sinusitis. In its active phase
the nasal discharge becomes purulent with progressive
destruction of nasal framework and mid-face. It all ends
with gross mutilation as well as systemic metastasis.

On radiological images, nasal T / NK cell lymphoma has
to be distinguished from a number of different entities
causing sinonasal destruction such as Wegener's
granulomatosis, other non-Hodgkin's lymphoma, granu-

lomatous infections, adenoid cystic carcinoma, olfactory
neuroblastoma, malignant melanoma, and squamous
cell carcinoma.4 Although, it leads to bony erosion of the
palate, alveolar bones and orbit, which are easily picked
up on computed tomographic scans, the fact remains
that these findings also correlate to a malignant neoplasm. Magnetic resonance imaging is helpful in evaluation of the disease extent but again it is non-specific.7

Untreated, nasal type of NK/T cell lymphoma is fatal.
Maeda et al. have reported that one year survival rate of
50% and 5 years survival rate of 23% for an untreated
condition.8 Chemotherapy (CHOP regimen) with
radiation therapy is the proposed treatment option.
Despite radiation and chemotherapy the overall survival
rate remains low.9
Discrepancies persist in the rates of local control rates
using radiation therapy as the modality in different
series. The favoured dose of radiation is at least 50 Gy.
Studies have shown the 5-year overall survival after
radiation therapy to be around 15 - 75%.10

Nasal type of NK/T cell lymphoma is a slow growing
condition, following a waxing and waning course. It
follows a downhill course in case of relapse or systemic
spread. Good cure and overall survival rates have been
observed, once diagnosed early and treated promptly.
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